s,n,n'-tripropylthiocarbamate has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Erdei, T; Gesztelyi, R; Juhasz, B; Kardos, L; Pak, K; Papp, C; Seres, I; Szentpéteri, A; Szilasi, M; Zsuga, J | 1 |
Altet Gómez, N; Barrueco Ferrero, M; de Granda Orive, JI; Jiménez-Ruiz, CA; Lorza Blasco, JJ; Martinez Muñiz, MA; Ramos Pinedo, A; Riesco Miranda, JA; Signes-Costa Miñana, J; Solano Reina, S | 1 |
2 other study(ies) available for s,n,n'-tripropylthiocarbamate and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Alteration of the irisin-brain-derived neurotrophic factor axis contributes to disturbance of mood in COPD patients.
Topics: Affect; Aged; Brain; Brain-Derived Neurotrophic Factor; Chi-Square Distribution; Cross-Sectional Studies; Depression; Female; Fibronectins; Forced Expiratory Volume; Humans; Linear Models; Lung; Male; Middle Aged; Multivariate Analysis; Pulmonary Disease, Chronic Obstructive; Quality of Life; Respiratory Function Tests; Reward; Risk Factors; Signal Transduction; Surveys and Questionnaires | 2017 |
Treatment of smoking in smokers with chronic obstructive pulmonary disease. Sociedad Española de Neumología y Cirugía Torácica (SEPAR).
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Follow-Up Studies; Humans; Motivation; Multicenter Studies as Topic; Program Evaluation; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Randomized Controlled Trials as Topic; Reward; Severity of Illness Index; Smoking; Smoking Cessation; Spain; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |